Guidance for Industry. Gamma Irradiation of Blood and Blood Components: A PilotProgram for Licensing

摘要

This document provides Food and Drug Administration (FDA) acceptable criteria forthe gamma irradiation of blood and blood components for transfusion. FDA believes that the procedures recommended in this document reflect practices currently in use by most manufacturers and represent the prevailing industry standard.